title: Long-term antibody memory induced by synthetic peptide vaccination is protective against Streptococcus pyogenes infection and is independent of memory T cell help.
abstract: Streptococcus pyogenes (group A Streptococcus [GAS]) is a leading human pathogen associated with a diverse array of mucosal and systemic infections. Vaccination with J8, a conserved region synthetic peptide derived from the M-protein of GAS and containing only 12 aa from GAS, when conjugated to diphtheria toxoid, has been shown to protect mice against a lethal GAS challenge. Protection has been previously shown to be Ab-mediated. J8 does not contain a dominant GAS-specific T cell epitope. The current study examined long-term Ab memory and dissected the role of B and T cells. Our results demonstrated that vaccination generates specific memory B cells (MBC) and long-lasting Ab responses. The MBC response can be activated following boost with Ag or limiting numbers of whole bacteria. We further show that these memory responses protect against systemic infection with GAS. T cell help is required for activation of MBC but can be provided by naive T cells responding directly to GAS at the time of infection. Thus, individuals whose T cells do not recognize the short synthetic peptide in the vaccine will be able to generate a protective and rapid memory Ab response at the time of infection. These studies significantly strengthen previous findings, which showed that protection by the J8-diphtheria toxoid vaccine is Ab-mediated and suggest that in vaccine design for other organisms the source of T cell help for Ab responses need not be limited to sequences from the organism itself.
authors: Institute for Glycomics, Griffith University, Gold Coast, Queensland 4222, Australia.
authors: Manisha
authors: M
authors: Pandey
authors: Michelle N
authors: MN
authors: Wykes
authors: Jon
authors: J
authors: Hartas
authors: Michael F
authors: MF
authors: Good
authors: Michael R
authors: MR
authors: Batzloff
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000008:administration & dosage / Q000096:biosynthesis*; D016175:B-Lymphocyte Subsets / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology*; D007117:Immunization, Secondary / Q000379:methods; D007156:Immunologic Memory / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D013290:Streptococcal Infections / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology* / Q000382:microbiology*; D013997:Time Factors; D022223:Vaccines, Subunit / Q000008:administration & dosage* / Q000276:immunology / Q000627:therapeutic use
chemical_list: D000907:Antibodies, Bacterial; D022223:Vaccines, Subunit
references: Nature. 1997 Jul 10;388(6638):133-4
references: 9217150
references: J Infect Dis. 2003 Jan 1;187(1):134-8
references: 12508157
references: J Infect Dis. 2003 May 15;187(10):1598-608
references: 12721940
references: Blood. 2007 Nov 1;110(9):3472-9
references: 17656648
references: Med J Aust. 1996 Feb 5;164(3):146-9
references: 8628132
references: J Immunol. 2008 Feb 15;180(4):2165-73
references: 18250423
references: PLoS Pathog. 2008 May 30;4(5):e1000078
references: 18516300
references: Adv Immunol. 1997;64:139-218
references: 9100982
references: Immunity. 1998 Mar;8(3):363-72
references: 9529153
references: Curr Opin Infect Dis. 2009 Dec;22(6):544-52
references: 19797947
references: J Exp Med. 1985 Jan 1;161(1):113-22
references: 2578539
references: J Infect Dis. 2000 Jun;181(6):2087-91
references: 10837200
references: Int Immunol. 1997 Nov;9(11):1723-33
references: 9418133
references: PLoS One. 2009;4(4):e5147
references: 19340309
references: Malar J. 2009 Jun 05;8:120
references: 19500348
references: J Immunol. 2002 Jun 1;168(11):5551-7
references: 12023350
references: Proc Natl Acad Sci U S A. 2009 May 12;106(19):7962-7
references: 19416838
references: Res Microbiol. 2005 May;156(4):575-82
references: 15862457
references: J Immunol Methods. 2009 Oct 31;350(1-2):29-35
references: 19647746
references: Nature. 1990 Aug 23;346(6286):749-51
references: 2388695
references: J Infect Dis. 1995 Jun;171(6):1576-85
references: 7769295
references: Pept Res. 1996 Jan-Feb;9(1):12-20
references: 8727479
references: J Immunol. 2011 Mar 1;186(5):2889-96
references: 21270407
references: J Immunol. 2010 Oct 1;185(7):4011-21
references: 20739675
references: Science. 2002 Dec 13;298(5601):2199-202
references: 12481138
references: Infect Immun. 2009 Sep;77(9):3850-6
references: 19528207
references: J Immunol. 2005 Aug 15;175(4):2510-6
references: 16081823
references: Eur J Immunol. 1986 Oct;16(10):1297-301
references: 3490389
references: J Immunol Methods. 1996 Nov 29;199(1):37-46
references: 8960096
references: Vaccine. 2011 Dec 9;30(1):51-8
references: 22064265
references: J Exp Med. 2004 Feb 16;199(4):593-602
references: 14769849
references: Vaccine. 1996 Aug;14(11):1019-27
references: 8879096
references: J Virol. 1995 Mar;69(3):1895-902
references: 7853531
references: J Exp Med. 1982 Oct 1;156(4):1165-76
references: 6185606
references: Curr Opin Immunol. 1998 Jun;10(3):252-8
references: 9638360
references: Vaccine. 2007 May 4;25(18):3567-73
references: 17293014
references: J Immunol. 1990 Dec 15;145(12):4089-93
references: 1701783
references: Clin Microbiol Rev. 2000 Jul;13(3):470-511
references: 10885988
references: J Exp Med. 1994 Jul 1;180(1):141-55
references: 7516404
references: Clin Vaccine Immunol. 2010 Jan;17(1):127-33
references: 19889937
references: Science. 1994 Sep 2;265(5177):1395-400
references: 8073282
references: Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13263-8
references: 11069289